ライフサイエンスソフトウェア市場規模、シェア、成長分析：展開別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

ライフサイエンスソフトウェアの世界市場規模は2023年に147億米ドルとなり、予測期間（2025-2032年）のCAGRは12.3%で、2024年の165億1,000万米ドルから2032年には417億6,000万米ドルに成長する見通しです。

ライフサイエンスソフトウェア市場は、製薬、バイオテクノロジー、医療機器分野の企業が業務、調査、規制遵守のために専用アプリケーションへの依存度を高めていることから、大きな成長を遂げています。この市場には、臨床検査情報管理システム（LIMS）、臨床試験管理システム（CTMS）、電子実験ノート（ELN）など、さまざまなソリューションが含まれます。デジタル化と自動化の急増に加え、精密医療への注目とバイオ医薬品研究の拡大が需要を牽引しています。さらに、研究開発における迅速な市場投入と生産性向上のニーズは、統合されたスケーラブルなソリューションの需要を強調しています。全体として、パーソナライゼーションとヘルスケア提供の改善に向けた動向は、ライフサイエンスソフトウェアを現代のヘルスケアとバイオテクノロジー産業における極めて重要な要素としてさらに強固なものにしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩
• ケーススタディ
• 特許分析
• 規制分析

ライフサイエンスソフトウェア市場規模：展開別& CAGR（2025-2032）

• 市場概要
• クラウド
• オンプレミス

ライフサイエンスソフトウェア市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 前臨床および臨床試験
• サプライチェーンマネジメント
• 研究開発
• 商業的エンゲージメントとブランディング
• 医薬品安全性監視
• 規制遵守

ライフサイエンスソフトウェア市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• バイオテクノロジーおよび製薬企業
• 医療研究センター
• 医療機器企業
• その他

ライフサイエンスソフトウェア市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Veeva Systems（United States）
• IQVIA（United States）
• Schrodinger, Inc.（United States）
• Accenture（Ireland）
• SAS Institute（United States）
• Oracle Corporation（United States）
• Microsoft Corporation（United States）
• IBM（United States）
• PerkinElmer（United States）
• Thermo Fisher Scientific（United States）
• Benchling（United States）
• ArisGlobal（United States）
• Medidata Solutions（United States）
• BioClinica（United States）
• PAREXEL International（United States）
• Dassault Systemes（France）
• IDBS（United Kingdom）
• LabWare（United States）
• Schrodinger（United States）
• Exscientia（United Kingdom）

結論と提言

Global Life Sciences Software Market size was valued at USD 14.7 billion in 2023 and is poised to grow from USD 16.51 billion in 2024 to USD 41.76 billion by 2032, growing at a CAGR of 12.3% during the forecast period (2025-2032).

The life sciences software market is experiencing significant growth as organizations in the pharmaceutical, biotechnology, and medical device sectors increasingly rely on specialized applications for operations, research, and regulatory compliance. This market encompasses a variety of solutions, including laboratory information management systems (LIMS), clinical trial management systems (CTMS), and electronic lab notebooks (ELN). The surge in digitization and automation, coupled with the focus on precision medicine and the expansion of biopharmaceutical research, is driving demand. Additionally, the need for quicker time-to-market and enhanced productivity in research and development emphasizes the demand for integrated, scalable solutions. Overall, the trend towards personalization and improved healthcare delivery further solidifies life sciences software as a pivotal component in modern healthcare and biotech industries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Life Sciences Software market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Life Sciences Software Market Segments Analysis

Global Life Sciences Software Market is segmented by Deployment, Application, End-user and region. Based on Deployment, the market is segmented into Cloud and On-premise. Based on Application, the market is segmented into Preclinical and Clinical Trials, Supply chain management, Research and Development, Commercial Engagement and Branding, Pharmacovigilance and Regulatory Compliance. Based on End-user, the market is segmented into Biotechnology and Pharmaceutical Companies, Medical Research Centers, Medical Device Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Life Sciences Software Market

One of the primary drivers fueling the growth of the Global Life Sciences Software market is the increasing pressure to expedite drug development pipelines. In light of urgent global health challenges, including pandemics and chronic diseases, pharmaceutical firms and research organizations are compelled to enhance the speed at which they identify, develop, and deliver new therapeutics. Life sciences software plays a critical role in this process by facilitating more efficient data management, analysis, and collaboration throughout the entire drug development lifecycle. As these health challenges continue to evolve, the demand for innovative software solutions within the life sciences sector is expected to rise significantly.

Restraints in the Global Life Sciences Software Market

One significant hindrance in the Global Life Sciences Software market is the high expense associated with these software solutions. The financial burden extends beyond mere purchase or subscription fees and encompasses additional costs related to integration, customization, training, and ongoing support. This can pose considerable challenges, especially for small to medium-sized enterprises (SMEs) and academic institutions, whose budgets may not accommodate such substantial investments. As a result, these financial constraints can severely limit their ability to adopt and effectively implement advanced software tools, thereby impeding their growth and innovation within the life sciences sector.

Market Trends of the Global Life Sciences Software Market

The Global Life Sciences Software market is experiencing significant growth driven by the incorporation of Artificial Intelligence (AI) and Machine Learning (ML). These advanced technologies are revolutionizing various facets of life sciences, including drug development, clinical trials, and patient diagnostics. By enabling the rapid analysis of vast datasets, AI and ML facilitate the discovery of valuable insights and patterns that enhance research efficacy and treatment strategies. This trend is not only streamlining processes but also fostering innovation, ultimately leading to improved healthcare outcomes and personalized medicine. As the adoption of AI and ML continues to rise, the life sciences software market is poised for robust expansion.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Case Studies
• Patent Analysis
• Regulatory Analysis

Global Life Sciences Software Market Size by Deployment & CAGR (2025-2032)

• Market Overview
• Cloud
• On-premise

Global Life Sciences Software Market Size by Application & CAGR (2025-2032)

• Market Overview
• Preclinical and Clinical Trials
• Supply chain management
• Research and Development
• Commercial Engagement and Branding
• Pharmacovigilance
• Regulatory Compliance

Global Life Sciences Software Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Biotechnology and Pharmaceutical Companies
• Medical Research Centers
• Medical Device Companies
• Others

Global Life Sciences Software Market Size & CAGR (2025-2032)

• North America (Deployment, Application, End-user)
  • US
  • Canada
• Europe (Deployment, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Deployment, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Deployment, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Deployment, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Veeva Systems (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schrodinger, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accenture (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAS Institute (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microsoft Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Benchling (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ArisGlobal (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medidata Solutions (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioClinica (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PAREXEL International (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dassault Systemes (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDBS (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabWare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schrodinger (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exscientia (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations